The bryostatins represent one of the medically most promising series of marine animal constituents presently known. Their discovery, chemistry and biology will be reviewed here beginning with a historical perspective.


High Performance Liquid Chromatography Marine Animal Life Extension Antineoplastic Activity Eastern Pacific Ocean 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kornberg, A.: The Two Cultures: Chemistry and Biology. Biochemistry 26, 6888 (1987).CrossRefGoogle Scholar
  2. 2.
    Harshbarger, J.C.: Invertebrate animals-what can they contribute to cancer research? Federat. Proc. (Amer. Soc. Exp. Biol.) 32, 2224 (1973).Google Scholar
  3. 3.
    Harshbarger, J.C., and C.J.Dawe: Hematopoietic Neoplasms in Invertebrate and Poikilothermic Vertebrate Animals. In: Unifying Concepts of Leukemia, Bibl. haemat. No. 39, (Dutcher, R.M., and L.Chieco-Bianchi, eds.), p. 1. Basel: Karger. 1973.Google Scholar
  4. 4.
    Pettit, G.R., J.F. Day, J.L. Hartwell, and H.B. Wood: Antineoplastic Components of Marine Animals. Nature 227, 962 (1970).CrossRefGoogle Scholar
  5. 5.
    Pettit, G.R., J.L. Hartwell, and H.B. Wood: Arthropod Antineoplastic Agents. Cancer Res. 28, 2168 (1968).Google Scholar
  6. 6.
    Pettit, G.R.: Biosynthetic Products for Cancer Chemotherapy, Vol. 1, p. 165. New York: Plenum Press. 1977.Google Scholar
  7. 7.
    Pettit, G.R., Y. Kamano, P. Drasar, M. Inoue, and J.C. KnighT: Synthesis of Bufalitoxin and Bufotoxin. J. Organ. Chem. (USA) 52, 3573 (1987).CrossRefGoogle Scholar
  8. 8.
    Pettit, G.R., L.E. Houghton, N.H. Rogers, R.M. Coomes, D.F. Berger, P.R. Reucroft, J.F. Day, J.L. Hartwell, and H.B. Wood, Jr.: Butterfly Wing Antineoplastic Agents. Experientia 28, 382 (1972).CrossRefGoogle Scholar
  9. 9.
    Pettit, G.R., and R.H. Ode: Antineoplastic Agents. 41. The Beetle Allomyrina dichotomus. Lloydia 39, 129 (1976).Google Scholar
  10. 10.
    Pettit, G.R., R.M. Blazer, and D.A. Reierson: Antineoplastic Agents. 51. The Yellow Jacket Vespula pensylvanica. Lloydia 40, 247 (1977).Google Scholar
  11. 11.
    Pettit, G.R., R.H. Ode, and T.B. Harvey, III: Isolation of Taurine from the Molluscs Macrocallista nimbosa and Turbo stenogyrus. Lloydia 36, 204 (1973).Google Scholar
  12. 12.
    Pettit, G.R., C.L. Herald, and D.L. Herald: Antineoplastic Agents XLV: Sea Cucumber Cytotoxic Saponins. J. Pharm. Sci. 65, 1558 (1976).CrossRefGoogle Scholar
  13. 13.
    Suffness, M., D.J. Newman, and K. Snader: Discovery and Development of Antineoplastic Agents from Natural Sources. In: Bioorganic Marine Chemistry, Volume 3, p. 131. Berlin-Heidelberg-New York-Tokyo Springer. 1989.Google Scholar
  14. 14.
    Biology of Bryozoans (Woollacott, R.M., and R.L. Zimmer, eds.). New York: Academic Press. 1977.Google Scholar
  15. 15.
    Mckinney, F.K., and J.B.C. Jackson: Bryozoan Evolution. In: Special Topics in Palaeontology, Volume 2, xiv, 238 pp. Winchester, MA: Unwin Hyman. 1989.Google Scholar
  16. 16.
    Ryland, J.S., and P.J. Hayward. British Anascan Bryozoans, Cheilostomata: Anasca. In: Synopses of the British Fauna No. 10, (Kermack, D.M., ed.), p. 1. London: Academic Press. 1977.Google Scholar
  17. 17.
    Pettit, G.R., C.L. Herald, D.L. Doubek, D.L. Herald, E. Arnold, and J. Clardy Google Scholar
  18. Isolation and Structure of Bryostatin 1.J.Amer. Chem. Soc. 104 6846 (1982).Google Scholar
  19. 18.
    Pettit, G.R., C.L. Herald, Y. Kamano, D. Gust, and R. Aoyagi: The Structure of Bryostatin 2 from the Marine Bryozoan Bugula neritina. J. Google Scholar
  20. Nat. Prod. 46 528 (1983).Google Scholar
  21. 19.
    Pettit, G.R., C.L. Herald, and Y. Kamano: Structure of the Bugula neritina (Marine Bryozoa) Antineoplastic Component Bryostatin 3. J. Organ. Chem. USA 48, 5354 (1983). See also ref. 40 below.Google Scholar
  22. 20.
    Pettit, G.R., Y. Kamano, C.L. Herald, and M. Tozawa: Structure of Bryostatin 4. An Important Antineoplastic Constituent of Geographically Diverse Bugula neritina (Bryozoa). J. Amer. Chem. Soc. 106, 6768 (1984).CrossRefGoogle Scholar
  23. 21.
    Idem Isolation and Structure of Bryostatins 5–7. Canad. J. Chem. 63, 1204 (1985).Google Scholar
  24. 22.
    Pettit, G.R., Y.Kamano, R. Aoyagi, C.L.Herald, D.L. Doubek, J.M. Schmidt, and J.J. Rudloe: Antineoplastic Agents 100. The Marine Bryozoan Amathia convoluta. Tetrahedron 41, 985 (1985).CrossRefGoogle Scholar
  25. 23.
    Pettit, G.R., J.E. Leet, C.L. Herald, Y. Kamano, and D.L. Doubek: Antineoplastic Agents, 116. An Evaluation of the Marine Ascidian Aplidium californicum. J. Nat. Prod. 49, 231 (1986).CrossRefGoogle Scholar
  26. 24.
    Morris, R.H., D.P. Abbott, and E.C. HaderliE, Intertidal Invertebrates of California, p. 177 and plate 57. Stanford, CA: 1980.Google Scholar
  27. 25.
    Pettit, G.R., Y. Kamano, and C.L. Herald: Antineoplastic Agents, 118. Isolation and Structure of Bryostatin 9. J. Nat. Prod. 49, 661 (1986).CrossRefGoogle Scholar
  28. 26.
    Pettit, G.R., C.W. Holzapfel, and G.M. Cragg: Mass Measurements of Natural Products by Solution Phase Secondary Ion Mass Spectrometry Employing Silver(I) and Thallium(I) Derivatives. J. Nat. Prod. 47, 941 (1984).CrossRefGoogle Scholar
  29. 27.
    Pettit, G.R., C.W. Holzapfel, G.M. Cragg, C.L. Herald, and P. Williams: Broad Scope Secondary Ion Mass Spectrometry. J. Nat. Prod. 46, 917 (1983).CrossRefGoogle Scholar
  30. 28.
    Pettit, G.R., Y.Kamano, and C.L. Herald: Isolation and Structure of Bryostatins 10 and 11. J. Organ. Chem. USA 52, 2848 (1987).CrossRefGoogle Scholar
  31. 29.
    Arene, E.O., G.R. Pettit, and R.H. ODE: The Isolation of Isosakuranetin Methyl Ether from Eupatorium odoratum. Lloydia 41, 186 (1978).Google Scholar
  32. 30.
    Bligh, E.G., and W.J. Dyer: A Rapid Method of Total Lipid Extraction and Purification. Canad. J. Biochem. Physiol. 37, 911 (1959).CrossRefGoogle Scholar
  33. 31.
    Pettit, G.R., Y. Fujii, J.A. Hasler, J.M. Schmidt, and C. Michel: Antineoplastic Agents 78. Isolation of Palystatins 1–3 from the Indian Ocean Palythoa liscia. J. Nat. Prod. 45, 263 (1982).CrossRefGoogle Scholar
  34. 32.
    Pettit, G.R., J.E. Leet, C.L. Herald, Y. Kamano, F.E. Boettner, L. Baczynskyj, and R.A. Nieman: Isolation and Structure of Bryostatins 12 and 13. J. Organ. Chem. (USA) 52, 2854 (1987).CrossRefGoogle Scholar
  35. 33.
    Pettit, G.R., Y. Kamano, C.L. Herald, J.M. Schmidt, and C.G. Zubrod: Relationship of Bugula neritina (Bryozoa) antineoplastic constituents to the yellow sponge Lissodendoryx isodictyalis. Pure & Appl. Chem. 58, 415 (1986).Google Scholar
  36. 34.
    Kocienski, P.J., D.A.S. Street, C. Yeates, and S.F. Cambell: The 3,4-Dihydro2H-pyran Approach to (+)-Milbemycin 33. Part 2. An Improved Synthesis of (2R,4S,6S,8R,9S)-2-[(5R)-(2E)-3-Methyl-5-formyl-hex-2-en-1-y1]-8,9-dimethyl-4- (dimethyl-t-butylsilyloxy)-1,7-dioxaspiro[5.5]-undecane. J. Chem. Soc. Perkin Trans I 1987, 2189.Google Scholar
  37. 35.
    Corey, E.J., and A. Venkateswarlu: Protection of Hydroxyl Groups as tert-Butyldimethylsilyl Derivatives. J. Amer. Chem. Soc. 94, 6190 (1972).CrossRefGoogle Scholar
  38. 36.
    Lalonde, M., and T.H. Chan: Use of Organosilicon Reagents as Protective Groups in Organic Synthesis. Synthesis 1985, 817.Google Scholar
  39. 37.
    Ziegler, F.E., A. Nangia, and G. Schulte: The Synthesis of Neosporol: A Trichothecene in Search of a Natural Product. Tetrahedron Letters 29, 1669 (1988).CrossRefGoogle Scholar
  40. 38.
    Pettit, G.R., Y. Kamano, D. Schaufelberger, C.L. Herald, P.M. Blumberg, and W.S. May: High Performance Liquid Chromatographic Separation of Bryostatins 1–12. J. Liquid Chromatog. 12, 553 (1989).CrossRefGoogle Scholar
  41. 38.
    Pettit, G.R., Y. Kamano, D. Schaufelberger, C.L. Herald, P.M. Blumberg, and W.S. May: High Performance Liquid Chromatographic Separation of Bryostatins 1–12. J. Liquid Chromatog. 12, 553 (1989).CrossRefGoogle Scholar
  42. 40.
    Pettit, G.R., D.L. HeralD, F. Gao, D. Sengupta and C.L. Herald: Absolute Configuration of the Bryostatins. J. Organ. Chem. (USA) 56, 1337 (1991).Google Scholar
  43. 41.
    Gignac, S.M., M. Buschle, G.R. Pettit, A.V. Hoffbrand, and H.G. Drexler Google Scholar
  44. Differential Expression of Trap Isoenzyme in B-CLL Cells Treated with Different Inducers. Leukemia & Lymphoma 3, 19 (1990).CrossRefGoogle Scholar
  45. 42.
    Baer, J.C., J.A. Slack, and G.R. Pettit: Stability-indicating high-performance liquid chromatography assay for the anticancer drug bryostatin 1. J. Chromatog. 467, 332 (1989).CrossRefGoogle Scholar
  46. 43.
    Kageyama, M., and S. Masamune: Studies Toward the Total Synthesis of Bryostatin 7. 31st Symposium on the Chemistry of Natural Products, Nagoya, Japan, 1989, 227.Google Scholar
  47. 44.
    Evans, D.A., E.M. Carreira, A.B. Charette, and J.A. Gauchet: Approaches to the Synthesis of Antineoplastic Macrolide Bryostatin. Amer. Chem. Soc. National Meeting, Dallas, Texas, April 10, 1989.Google Scholar
  48. 45.
    Y Nishizuka: The Family of Protein Kinase C for Signal Transduction. J. Amer. Med. Assoc. 262, 1826 (1989).Google Scholar
  49. 46.
    Blumberg, P.M., G.R. Pettit, B.S. Warren, A. Szallasi, L.D. Schuman, N.A. Sharkey, H. Nakakuma, M.L. Dell’aquila, and D.J. De Vries: The Protein Kinase C Pathway in Tumor Promotion. In: Skin Carcinogenesis: Mechanisms and Human Relevance, p. 201. Alan R. Liss, Inc. 1989.Google Scholar
  50. 47.
    Smith, J.B., L. Smith, and G.R. Pettit. Bryostatins: Potent, New Mitogens that Mimic Phorbol Ester Tumor Promoters. Biochem. Biophys. Res. Comm. 132, 939 (1985).CrossRefGoogle Scholar
  51. 48.
    Sako, T., S.H. Yuspa, C.L. Herald, G.R. Pettit, and P.M. Blumberg: Partial Parallelism and Partial Blockade by Bryostatin 1 of Effects of Phorbol Ester Tumor Promoters on Primary Mouse Epidermal Cells. Cancer Res. 47, 5445 (1987).Google Scholar
  52. 49.
    Hennings, H., P.M. Blumberg, G.R. Pettit, C.L. Herald, R. Shores, and S.H. Yuspa: Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8, 1343 (1987).CrossRefGoogle Scholar
  53. 50.
    Yuspa, S.H., H. Hennings, T. Sako, G.R. Pettit, J. Hartley, and P.M. Blumberg:Google Scholar
  54. Tumor Promotion: A Problem of Differential Responses of Normal and Neoplastic Cells to Trophic Stimuli. In: Anticarcinogenesis and Radiation Protection (Cerutti, P.A., O.F. Nygaard, and M.G. Simic, eds.), p. 169. Plenum Pub. Corp. 1987.Google Scholar
  55. 51.
    Gschwendt, M., G. Furstenberger, S. Rose-john, M. Rogers, W. Kittstein, G.R. Pettit, C.L. Herald, and F. Marks: Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. Carcinogenesis 9, 555 (1988).CrossRefGoogle Scholar
  56. 52.
    Dell’aquila, M.L., H.T. Nguyen, C.L. Herald, G.R. Pettit, and P.M. Blumberg Google Scholar
  57. Inhibition by Bryostatin 1 of the Phorbol Ester-induced Blockage of Differentiation in Hexamethylene Bisacetamide-treated Friend Erythroleukemia Cells. Cancer Res. 47, 6006 (1987).Google Scholar
  58. 53.
    Kiss, Z., E. Deli, P.R. Girard, G.R. Pettit, and J.F. Kuo: Comparative Effects of Polymyxin B, Phorbol Ester and Bryostatin on Protein Phosphorylation, Protein Kinase C Translocation, Phospholipid Metabolism and Differentiation of HL60 Cells. Biochem. Biophys. Res. Comm. 146, 208 (1987).CrossRefGoogle Scholar
  59. 54.
    Garrison, J.C., G.R. Pettit, and E.M. Uyeki: Effect of Phorbol and Bryostatin I on Chondrogenic Expression of Chick Limb Bud, in vitro. Life Sciences 41, 2055 (1987).CrossRefGoogle Scholar
  60. 55.
    Pasti, G., E. Rivedal, S.H. Yuspa, C.L. Herald, G.R. Pettit, and P.M. Blumberg: Contrasting Duration of Inhibition of Cell-Cell Communication in Primary Mouse Epidermal Cells by Phorbol 12,13-Dibutyrate and by Bryostatin 1. Cancer Res. 48, 447 (1988).Google Scholar
  61. 56.
    Dell’Aquila, M.L., C.L. Herald, Y. Kamano, G.R. Pettit, and P.M. Blumberg Google Scholar
  62. Differential Effects of Bryostatins and Phorbol Esters on Arachidonic Acid Metabolite Release and Epidermal Growth Factor Binding in C3H 10T1/2 Cells. Cancer Res. 48, 3702 (1988).Google Scholar
  63. 57.
    Warren, B.S., Y. Kamano, G.R. Pettit, and P.M. Blumberg: Mimicry of Bryostatin 1 Induced Phosphorylation Patterns in HL-60 Cells by High Phorbol Ester Concentrations. Cancer Res. 48, 5984 (1988).Google Scholar
  64. 58.
    De Vries, D.J., C.L. Herald, G.R. Pettit, and P.M. Blumberg: Demonstration of Sub-Nanomolar Affinity of Bryostatin 1 for the Phorbol Ester Receptor in Rat Brain. Biochem. Pharmacol. 37, 4069 (1988).CrossRefGoogle Scholar
  65. 59.
    Parker, J., M. Waite, G.R. Pettit, and L.W. Daniel: Stimulation Of arachidonic acid release and prostaglandin synthesis by bryostatin 1. Carcinogenesis 9, 1471 (1988).CrossRefGoogle Scholar
  66. 60.
    Jetten, A.M., M.A. George, G.R. Pettit, C.L. Herald, and J.I. Rearich: Action of Phorbol Esters, Bryostatins, and Retinoic Acid on Cholesterol Sulfate Synthesis: Relation to the Multistep Process of Differentiation in Human Epidermal Keratinocytes. J. Invest. Dermatol. 93, 108 (1989).CrossRefGoogle Scholar
  67. 61.
    Wender, P.A., C.M. Cribbs, K.F. Koehler, N.A. Sharkey, C.L. Herald, Y. Kamano, G.R. Pettit, and P.M. Blumberg: Modeling of the Bryostatins to the Phorbol Ester Pharmacophore on Protein Kinase C. Proc. Nat. Acad. Sci. (USA) 85, 7197 (1988).CrossRefGoogle Scholar
  68. 62.
    Trenn, G., G.R. Pettit, H. Takayama, J. H.-Li, and M.V. Sitkovsky: Immunomodulating Properties of a Novel Series of Protein Kinase C Activators. J. Immunology 140, 433 (1988).Google Scholar
  69. 63.
    Mohr, H., G.R. Pettit, and A. Plessing-Menze: Co-Induction of Lymphokine Synthesis by the Antineoplastic Bryostatins. Immunobiol. 175, 420 (1987).CrossRefGoogle Scholar
  70. 64.
    Hess, A.D., M.K. Silanskis, A.H. Esa, G.R. Pettit, and W.S. May: Activation of Human T Lymphocytes by Bryostatin. J. Immunology 141, 3263 (1988).Google Scholar
  71. 65.
    Golde, D.W., and J.C. Gasson: Hormones that Stimulate the Growth of Blood Cells. Scient. Amer. 1988 July, p. 62.Google Scholar
  72. 66.
    Laver, J., and M.A.S. Moore: Clinical Use of Recombinant Human Hematopoietic Growth Factors. J. Nat. Cancer Inst. 81, 1370 (1989).CrossRefGoogle Scholar
  73. 67.
    Metcalf, D.: Haemopoietic growth factors: Therapeutics. Med. J. Australia 148, 516 (1988).Google Scholar
  74. 68.
    May, W.S., S.J. Sharkis, A.H. Esa, V. Gebbia, A.S. Kraft, G.R. Pettit, and L.L. Sensenbrenner: Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proc. Nat. Acad. Sci. (USA) 84, 8483 (1987).CrossRefGoogle Scholar
  75. 69.
    Leonard, J.P., W.S. May, J.N. Ihle, G.R. Pettit, and S.J. Sharkis: Regulation of Hematopoiesis IV: The Role of Interleukin-3 and Bryostatin 1 in the Growth of Erythropoietic Progenitors from Normal and Anemic W/W Mice. Blood 72, 1492 (1988).Google Scholar
  76. 70.
    Fields, A.P., G.R. Pettit, and W.S. May: Phosphorylation of Lorain B at the Nuclear Membrane by Activated Protein Kinase C. J. Biol. Chem. 263, 8253 (1988).Google Scholar
  77. 71.
    Mcbain, J.A., G.R. Pettit, and G. Mueller: Bryostatin 1 Antagonizes the Terminal Differentiating Action of 12-O-Tetradecanoylphorbol-13-acetate in a Human Colon Cancer Cell. Carcinogenesis 9, 123 (1988).CrossRefGoogle Scholar
  78. 72.
    Kiss, Z., E. Deli, M. Shoji, H.P. Koeffler, G.R. Pettit, W.R. Vogler, and J.F. Kuo: Differential Effects of Various Protein Kinase C Activators on Protein Phosphorylation in Human Acute Myeloblastic Leukemia Cell Line KG-1 and Its Phorbol Ester-resistant Subline KG-la. Cancer Res. 47, 1302 (1987).Google Scholar
  79. 73.
    Stone, R.M., E. Sariban, G.R. Pettit, and D.W. Kufe: Bryostatin 1 Activates Protein Kinase C and Induces Monocytic Differentiation of HL-60 Cells. Blood 72, 208 (1988).Google Scholar
  80. 74.
    Kraft, A.S., F. William, G.R. Pettit, and M.B. Lilly: Varied Differentiation Responses of Human Leukemias to Bryostatin 1. Cancer Res. 49, 1287 (1989).Google Scholar
  81. 75.
    Jetten, A.M., M.A. George, G.R. Pettit, and J.I. Rearick: Effects of Bryostatins and Retinoic Acid on Phorbol Ester-and Diacylglycerol-induced Squamous Differentiation in Human Tracheobronchial Epithelial Cells. Cancer Res. 49, 3990 (1989).Google Scholar
  82. 76.
    Dale, LL., T.C. Bradshaw, A. Gescher, and G.R. Pettit: Comparison of Effects of Bryostatins 1 and 2 and 12-O-Tetradecanoylphorbol-13-acetate on Protein Kinase C Activity in A549 Human Lung Carcinoma Cells. Cancer Res. 49, 3242 (1989).Google Scholar
  83. 77.
    Drexler, H.G., S.M. Gignac, R.A. Jones, C.S. Scott, G.R. Pettit, and A.V. Hoffbrand: Bryostatin 1 Induces Differentiation of B-Chronic Lymphocytic Leukemia Cells. Blood 74, 1747 (1989).Google Scholar
  84. 78.
    Drexler, H.G., S.M. Gignac, G.R. Pettit, and A.V. Hoffbrand: Synergistic Action of Calcium Ionophore A23187 and Protein Kinase C activator Bryostatin 1 on Human B Cell Activation and Proliferation. Eur. J. Immunology 20, 119 (1990).CrossRefGoogle Scholar
  85. 79.
    Adamson, R.h., B. Chabner, and H. Funxt: U.S.—Japan Seminar on “Marine Natural Products and Cancer”. Jpn. J. Cancer Res. 80, 1141 (1989).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • G. R. Pettit
    • 1
  1. 1.Cancer Research Institute and Department of ChemistryArizona State UniversityTempeUSA

Personalised recommendations